Yun Xu

Title: The Innovative Contributions of Yun Xu

Introduction

Yun Xu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing topical preparations that address skin toxicity caused by anti-tumor drugs. His work is characterized by a focus on enhancing the efficacy of treatments for patients undergoing cancer therapy.

Latest Patents

Yun Xu holds a patent for a topical preparation containing vitamin K1 and its preparation method. This innovative formulation includes 0.01-5% of vitamin K1, 0.1-25% of a transdermal enhancer, and 70-99% of a matrix for the topical preparation. The transdermal enhancer is composed of urea, menthol, and oil in a specific mass ratio. This preparation is designed to treat moderate and severe skin toxicity related to epidermal growth factor receptor (EGFR) anti-tumor drugs. It effectively addresses conditions such as acne-like rash, pruritus, red swelling, dry skin, and mucositis, thereby facilitating continued treatment with anti-EGFR targeting drugs.

Career Highlights

Yun Xu is associated with Yangzijiang Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative solutions that improve patient care in oncology. His patent reflects his commitment to addressing the side effects of cancer treatments, which can significantly impact patients' quality of life.

Collaborations

Yun Xu has collaborated with notable colleagues, including Haihua Ni and Xinguo Jiang. These partnerships have likely contributed to the development and refinement of his innovative pharmaceutical solutions.

Conclusion

Yun Xu's contributions to the field of pharmaceuticals, particularly through his patent for a topical preparation containing vitamin K1, demonstrate his dedication to improving treatment outcomes for patients facing the challenges of cancer therapy. His work exemplifies the importance of innovation in addressing medical needs.